Related Experiment Video
Updated: Feb 13, 2026

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Heart transplantation from donation after circulatory determined death
Aravinda Page1, Simon Messer1, Stephen R Large1
1Department of Transplantation, Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridgeshire, UK.
Insights
Heart transplantation from donation after circulatory determined death (DCD) offers a promising solution to donor heart shortages. Recent advancements show DCD heart transplants are comparable to traditional donation after brain death (DBD) procedures.
Area of Science:
- Cardiology
- Transplantation Medicine
- Organ Donation
Background:
- Heart transplantation is the optimal treatment for end-stage heart failure, significantly improving patient quality of life.
- The primary limitation to heart transplantation is the scarcity of suitable donor organs.
- Historically, heart donation has relied exclusively on donors following brain stem death (DBD).
Purpose of the Study:
- To evaluate the viability and outcomes of heart transplantation using organs from donors after circulatory determined death (DCD).
- To address the global shortage of donor hearts by exploring DCD as a supplementary source.
- To compare the efficacy of DCD heart transplantation with the established DBD standard.
Main Methods:
- Review of established DCD heart transplant programs.
- Analysis of organ perfusion and retrieval techniques for DCD donors.
- Comparative outcome analysis between DCD and DBD heart transplant recipients.
Main Results:
- Recent developments in organ perfusion and retrieval have made DCD hearts a viable option.
- Established DCD heart transplant programs report encouraging and comparable results to DBD.
- DCD heart transplantation is emerging as a critical strategy to overcome donor organ scarcity.
Conclusions:
- Heart transplantation from DCD donors is a safe and effective procedure.
- DCD heart transplantation offers comparable outcomes to DBD, providing a vital solution to donor shortages.
- The advancement of DCD heart transplantation represents a significant development in the field, expanding therapeutic options for heart failure patients.
Abstract:
Fifty years since the first successful human heart transplant from a non-heart beating donor, this concept of heart transplantation from donation after circulatory determined death (DCD) promises to be one of the most exciting developments in heart transplantation. Heart transplantation has established itself as the best therapeutic option for patients with end-stage heart failure, with the opportunity to provide these patients with a near-normal quality of life. However, this treatment is severely limited by the availability of suitable donor hearts. In recent times, heart transplantation has been limited to using donor hearts from donors following brain stem death. The use of donor hearts from DCD had been thought to be associated with high risk and poor outcomes until recent developments in organ perfusion and retrieval techniques have shown that this valuable resource may provide an answer to the global shortage of suitable donor hearts. With established DCD heart transplant programmes reporting encouraging results, this technique has been shown to be comparable to the current gold standard of donation after brain death (DBD) heart transplantation.
Related Concept Videos
Anatomy of the Circulatory System
Determining the pH of Salt Solutions
Anatomy of the Heart
Anatomy of the Heart
The heart has three layers: the innermost endocardium, the muscular myocardium, and the outer epicardium, all working together for optimal cardiac function.
Chambers of the Heart
The heart is made up of four...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

